by Madaline Spencer | Jul 16, 2025
Erin Dunbar, MD, founding physician of the Brain Tumor Center and Director of Neuro-Oncology at Piedmont Atlanta Hospital, discusses the current landscape of glioblastoma. Glioblastoma is a malignant brain tumor that develops from an astrocyte brain...
by Madaline Spencer | Jul 15, 2025
Takeda has announced positive data from two phase 3 clinical trials of oveporexton in patients with narcolepsy type 1 (NT1). NT1 is a rare, chronic neurological disorder characterized by excessive daytime sleepiness (EDS) and cataplexy. It is caused by reduced levels...
by Madaline Spencer | Jul 15, 2025
David Liang, MD, PhD, Cardiologist at Hoag Hospital, discusses the diagnosis and management of Marfan syndrome. Marfan syndrome is a rare genetic disorder characterized by problems in the development of connective tissue. This leads to changes in the...
by Madaline Spencer | Jul 14, 2025
David Kuter, MD, DPhil, Director of Clinical Hematology at Massachusetts General Hospital, discusses recent results of a trial of mezagitamab in patients with immune thrombocytopenia (ITP). ITP is an autoimmune bleeding disorder characterized by too few...
by Madaline Spencer | Jul 11, 2025
Surbhi Sidana, MD, Hematologist and Associate Professor at Stanford University, discusses effects of ciltacabtagene autoleucel (cilta-cel) in patients with multiple myeloma (MM). MM is a bone marrow-based plasma cell neoplasm characterized by a serum...
